4 / 21
Page 29
Notes:
conferenceseries
.com
Volume 9
Journal of Nanomedicine & Nanotechnology
Nanotechnology Congress 2018
October 15-17, 2018
October 15-17, 2018 Dubai, UAE
21
st
World
Nanotechnology Congress
Nano-theranostic lipoprotein-inspired zinc oxide-bound paclitaxel for enhanced anticancer photo-
chemotherapy
Yaw Opoku Damoah
The University of Queensland, Australia
W
ith the emergence of nanotechnology, there is a pressing need for novel bio-friendly drug delivery systems which are
capable of eliminating all the constraints related to traditional treatment regimens. Driven by this need, this work
encompasses drug targeting via reconstituted High-Density Lipoproteins (rHDL), chemotherapy, photodynamic therapy and
in vitro
nano-inspired theranostics. Herein, we successfully fabricated zinc oxide-bound paclitaxel (ZnO/PTX) and packaged
the photo-chemotherapeutic formulation into rHDLs via one-pot synthesis. The final rHDLmediated ZnO/PTX nanomedicine
(rHDL/ZnO/PTX) shared a characteristic near-spherical shape and FTIR analysis proved that ZnO was successfully bound to
PTX via hydrogen bonding. The PTX and ZnO drug release pattern was analyzed by HPLC and ICP-OES analysis, respectively.
The results suggested that ZnO could remain intact in neutral medium but could gradually dissolve in acidic media to trigger
the collapse of the nanoparticle. The
in vitro
antitumor efficacy on A549 cells was evaluated by MTT assay and flow cytometry.
The final nanoparticle irradiated with UV light proved to be the most efficient treatment group. This was further confirmed
by the quantitative and qualitative detection of Reactive Oxygen Species (ROS) which indicates the apoptotic ability. Confocal
laser scanning microscopy was used to detect the presence of ROS and the resulting images suggested that rHDL/ZnO/PTX
could produce significant quantities of ROS. Flow cytometry analysis was employed to confirm that the fluorescence was more
conspicuous in cells that were irradiated with UV light as compared to those without UV irradiation. We further employed
flow cytometry to evaluate the existence of apoptotic and necrotic cells after a period of treatment. Moreover, ZnO fluorescence
was adapted to track intracellular trafficking, suggesting that rHDL/ZnO/PTX could be harnessed for UV light-mediated
photo-chemotherapy while apolipoprotein A-I (apoA-I) could help facilitate the shuttling of drugs into cancer cells via SR-BI
receptors. In addition, we demonstrated that ZnO could be used as a potential
in vitro
theranostic moiety which could mediate
photodynamic therapy and pH-responsive drug delivery.
Biography
Yaw Opoku Damoah has completed his BSc from the University of Cape Coast, Ghana. He is a Graduate of the China Pharmaceutical University where he has
pursued Postgraduate studies in Pharmaceutics. As part of his national service, he has worked with the Import and Export Control Department of the Food and
Drugs Authority, Ghana. His research is focused on nanotechnology, drug delivery and theranostics. He is specifically interested in the use of nano-theranostics
for site-specific delivery and diagnosis. He is currently a PhD (Pharmaceutics) candidate at the Australian Institute for Bioengineering and Nanotechnology, The
University of Queensland, Brisbance, Queensland, Australia.
yawdamoah@gmail.comYaw Opoku Damoah, J Nanomed Nanotechnol 2018, Volume 9
DOI: 10.4172/2157-7439-C9-091